PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-34.92%
Both yoy net incomes decline, with TSM at -16.08%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-0.94%
Negative yoy D&A while TSM is 4.40%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
182.43%
Some yoy growth while TSM is negative at -9.65%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
6.64%
SBC growth while TSM is negative at -16.13%. John Neff would see competitor possibly controlling share issuance more tightly.
1682.13%
Well above TSM's 187.98% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-27.95%
AR is negative yoy while TSM is 290.14%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-149.77%
Both reduce yoy inventory, with TSM at -85.59%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
50.65%
AP growth well above TSM's 61.27%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
260.97%
Growth well above TSM's 389.50%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
121.53%
Lower 'other non-cash' growth vs. TSM's 1124.45%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
67.96%
Operating cash flow growth above 1.5x TSM's 11.46%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-15.75%
Negative yoy CapEx while TSM is 23.70%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-4.55%
Both yoy lines negative, with TSM at -157415.63%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-1.55%
We reduce yoy sales while TSM is 124.68%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-13.61%
Both yoy lines negative, with TSM at -18.98%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-2249.89%
We cut debt repayment yoy while TSM is 93.12%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-62.54%
Negative yoy issuance while TSM is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.